Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 6, 2002, Pages 478-481

  Loeb, David M ^a   Hill, D Ashley ^a   Dome, Jeffrey S ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cancer recurrence; Chemotherapy; Congenital infantile fibrosarcoma; Mesoblastic nephroma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; RNA; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 15; DISEASE ASSOCIATION; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; FIBROSARCOMA; HUMAN; INFANT; MEDICAL LITERATURE; MESOBLASTIC NEPHROMA; NEWBORN; PRIORITY JOURNAL; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; DACTINOMYCIN; DOXORUBICIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEPHROMA, MESOBLASTIC; PROGNOSIS; RISK FACTORS; VINCRISTINE;

EID: 0036693895     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200208000-00014     Document Type: Article

References (27)

1. Marsden HB, Lawler W. Primary renal tumours in the first year of life. A population-based review. Virchows Arch A 1983;399:1-9.
2. Beckwith JB, Weeks DA. Congenital mesoblastic nephroma. When should we worry? Arch Pathol Lab Med 1986;110:98-9.
3. Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy II establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998;58:5046-8.
4. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998;153:1451-8.
5. Knezevich SR, McFadden DE, Tao W, et al a]. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998;18:184-7.
6. Gormley TS, Skoog SJ, Jones RV, Maybee D. Cellular congenital mesoblastic nephroma: What are the options. J Urol 1989;142:479-83.
7. Argani P, Fritsch M, Kadkol SS, et al. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol 2000;13:29-36.
8. Joshi VV, Kasznica J, Walters TR. Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med 1986;110:100-6.
9. Bolande RP, Brough AJ, Izant RJ Jr. Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics 1967;40:272-8.
10. Haas JE, Bonadio JF, Beckwith JB. Clear cell sarcoma of the kidney with emphasis on ultrastructural studies. Cancer 1984;54:2978-87.
11. Cofer BR, Vescio PJ, Wiener ES. Infantile fibrosarcoma: complete excision is the appropriate treatment. Ann Surg Oncol 1996;3:159-61.
12. Grier HE, Perez-Atayde AR, Weinstein HJ. Chemotherapy for inoperable infantile fibrosarcoma. Cancer 1985;56:1507-10.
13. Kurkchubasche AG, Halvorson EG, Forman EN, et al. The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma. J Pediatr Surg 2000;35:880-3.
14. Kynaston JA, Malcolm AJ, Craft AW. et al. Chemotherapy in the management of infantile fibrosarcoma. Med Pediatr Oncol 1993;21:488-93.
15. Shetty AK, Yu LC, Gardner RV, Warrier RP. Role of chemotherapy in the treatment of infantile fibrosarcoma. Med Pediatr Oncol 1999;33:425-7.
16. Fu Y, Kay S. Congenital mesoblastic nephroma and its recurrence. Arch Pathol 1973;96:66-70.
17. Joshi VV, Kay S, Milsten R, et al. Congenital mesoblastic nephroma of infancy: report of a case with unusual clinical behavior. Am J Clin Pathol 1973;110:811-6.
18. Walker D, Richard GA. Fetal hamartoma of the kidney: recurrence and death of patient. J Urol 1973;110:352-3.
19. Gonzalez-Crussi F, Sotelo-Avila C, Kidd JM. Malignant mesenchymal nephroma of infancy: report of a case with pulmonary metastases. Am J Surg Pathol 1980;4:185-90.
20. Howell CG, Othersen HB, Kiviat NE, ct al. Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms' Tumor Study. J Pediatr Surg 1982;17:826-31.
21. Steinfeld AD, Crowley CA, O'Shea PA, Tefft M. Recurrent and metastatic mesoblastic nephroma in infancy. J Clin Oncol 1984;2:956-60.
22. Chellama VG, Chacko E. Congenital mesoblastic nephroma study of 7 cases-report of a case of atypical mesoblastic nephroma. Indian J Cancer 1986;23:238-46.
23. Chan HS, Cheng MY, Mancer K, et al. Congenital mesoblastic nephroma: a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr 1987;111:64-70.
24. Heidelberger KP, Ritchey ML, Dauser RC, et al. Congenital mesoblastic nephroma metastatic to the brain. Cancer 1993;72:2499-502.
25. Ali AA, Finlay JL, Gerald WL, et al. Congenital mesoblastic nephroma with metastasis to the brain: a case report. Am J Pediatr Hematol Oncol 1994;16:361-4.
26. Dickerhoff R, Weirich A, Harms D, Schmidt D. Successful therapy of local recurrence of congenital mesoblastic nephroma [in German]. Klin Padiatr 1995;207:48-51.
27. Sane SY, Badhe PB, Kulkarni BK. Atypical mesoblastic nephroma. A potentially malignant variant of congenital mesoblastic nephroma. Review of literature and report of four cases. Indian J Cancer 1996;33:6-11.